Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan.

ChunLei Li,Xi Zhao,YaJuan Wang,HanYu Yang,HaiXia Li,Huan Li,Wei Tian,Jian Yang,JingXia Cui
DOI: https://doi.org/10.1016/j.ijpharm.2013.01.012
IF: 6.51
2013-01-01
International Journal of Pharmaceutics
Abstract:The prolongation of time interval between doses from 1 week (A) to 4 weeks (B) could eliminate the accelerated blood clearance phenomenon induced by pegylated liposomal topotecan.
What problem does this paper attempt to address?